Back to search

Cornell University

Glycoengineered Vesicle Vaccine Against Bacterial Pathogens

Abstract

dc:description.abstract

Vaccines are undoubtedly one of the greatest medical successes in human history, saving countless lives and billions of dollars through preventative medicine. Diseases such as measles, polio and smallpox have all been but eradicated. However, previous approaches to vaccine development using live attenuated or inactivated pathogens have stalled against pathogens with more sophisticated pathogenesis or are difficult to culture at a large scale. Whereas early approaches to vaccination sought to use whole organisms, and current approaches focus on the design of synthetic particles, our work seeks to harness the ability of Escherichia coli as a recombinant expression platform and its ability to produce nanoscale outer membrane vesicles (OMVs) as an all-in-one vaccine delivery system in vivo. Outer membrane vesicles (OMVs) have been shown to deliver recombinant protein antigens along with immunostimulatory components in a naturally produced liposome that closely mimics live pathogens. In this work, we have engineered E. coli OMVs to recombinantly display pathogenic carbohydrate structures bacterial pathogens such as Neisseria meningitidis and Francisella tularensis as well as the tumor-associated T antigen. These glycoengineered OMVs (glycOMVs) have shown to elicit a robust adaptive immune response in vaccinated mice as indicate by a significant increase in production of carbohydrate-specific antibodies. Furthermore, we have been able to demonstrate that vaccination with F. tularensis OMVs confers protection in mice against subsequent infection by the pathogen. These experiments serve as a proof-of-concept model that highlights the versatility of OMVs as a novel vaccine platform.

Degree

thesis:*
Name thesis:degree_name
Ph. D., Chemical Engineering
Level thesis:degree_level
Doctor of Philosophy
Discipline thesis:degree_discipline
Chemical Engineering
Grantor
Cornell University
Year dc:date.issued
2016

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Chen, Linxiao
Chair dc:contributor.chair
  • Delisa,Matthew
Committee members dc:contributor.committeemember
  • Chang,Yung-Fu
  • Putnam,David A.

Subjects

dc:subject × 3

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Dc Identifier Bibid
9597152

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Chen, Linxiao. Glycoengineered Vesicle Vaccine Against Bacterial Pathogens. Doctor of Philosophy thesis, Cornell University, 2016. https://hdl.handle.net/1813/43666